Elucidating Amyloid β-Protein Folding and Assembly: A Multidisciplinary Approach

Citations Over TimeTop 10% of 2006 papers

Abstract

Oligomeric, neurotoxic amyloid protein assemblies are thought to be causative agents in Alzheimer's and other neurodegenerative diseases. Development of oligomer-specific therapeutic agents requires a mechanistic understanding of the oligomerization process. This is a daunting task because amyloidogenic protein oligomers often are metastable and comprise structurally heterogeneous populations in equilibrium with monomers and fibrils. A single methodological approach cannot elucidate the entire protein assembly process. An integrated multidisciplinary program is required. We discuss here the synergistic application of in hydro, in vacuo, and in silico methods to the study of the amyloid beta-protein, the key pathogenetic agent in Alzheimer's disease.

Related Papers

• → Protein Aggregation and Its Consequences for Human Disease(2006)171 cited
• → Advances in the Simulation of Protein Aggregation at the Atomistic Scale(2016)130 cited
• → Pathways of amyloid fibril formation and protein aggregation(2024)2 cited
• → S100A9 Inhibits and Redirects Prion Protein 89-230 Fragment Amyloid Aggregation(2024)1 cited
• → Experimental techniques for detecting and evaluating the amyloid fibrils(2024)